HAO2 and hypertensive disorder: Inhibition of hydroxyacid oxidase 2 (HAO2) in the reduced kidney model led to reduced glutamate, glycine, and serine reabsorption suggesting a possible role for HAO2 in the hypertensive side effect following CETP inhibitor treatment based on the association of amino acid reabsorption with vasodilation and hypertension (see Table 1).